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Epithelial organogenesisDespite their importance to oral health, themechanisms of minor salivary gland (SG) development are largely
unexplored. Here we present in vivo and in vitro analyses of developing minor SGs in wild type and mutant
mice. Eda, Shh and Fgf signalling pathway genes are expressed in these glands from an early stage of
development. Developing minor SGs are absent in Eda pathway mutant embryos, and these mice exhibit a
dysplastic circumvallate papilla with disrupted Shh expression. Supplementation of Eda pathway mutant
minor SG explants with recombinant EDA rescues minor SG induction. Supplementation with Fgf8 or Shh,
previously reported targets of Eda signalling, leads to induction of gland like structures in a few cases, but
these fail to develop into minor SGs.).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Salivary glands (SGs) have an important role in providing
lubrication for digestion and protection of the oral tissues. In addition
to the major SGs (reviewed in Tucker (2007)), the mammalian oral
cavity also contains many minor SGs. These small glands provide
ongoing protection to the oral tissues by secreting saliva continuously
(Hand et al., 1999). Furthermore, study of developing minor SGs may
reveal new information about the development of related epithelial
structures such as the hair follicles, teeth or other glands. Despite their
importance to oral health and potential interest to developmental
biologists, the mechanisms of minor salivary gland (SG) development
are largely unexplored.
The minor SGs are located in the submucosa of the tongue, cheeks
and palate and secrete mostly mucus saliva. These glands are simpler
in structure than the major SGs, lacking a complex branched ductal
system and existing continuously within the surrounding connective
tissue, rather than within a mesenchyme capsule (Hand et al., 1999).
The development of the murine submandibular gland (SMG), the
largest major SG, has been clearly characterized and develops from a
thickening of the oral epithelium at E11.5, subsequently undergoing
bud formation, branching morphogenesis and terminal differentia-
tion. This process involves an array of signalling pathways including
Sonic Hedgehog (Shh), Fibroblast Growth Factor (Fgf) and Ectodys-
plasin A (Eda) (Jaskoll andMelnick, 1999; Hoffman et al., 2002; Jaskoll
et al., 2004a,b; Wells et al., 2010). By contrast, information on thegenes involved in minor SG development is lacking, although it has
been shown that the homeobox transcription factor Nkx3.1 is
expressed during mouse minor SG development and plays a role in
duct morphogenesis (Schneider et al., 2000).
The Eda signalling pathway is required for ectodermal organ
development. Mutations in Eda pathway genes cause hypohidrotic
ectodermal dysplasia (HED), characterized by defective development
of the hair, teeth and exocrine glands (Clarke et al., 1987). EDA
encodes the tumour necrosis factor-like ligand EDA A1 (Srivastava et
al., 1997). EDA A1 signals through its receptor EDAR and an
intracellular adaptor protein EDARADD (Headon et al., 2001), and
instigates downstream activation of NFκB (Kumar et al., 2001).
Recessive mutations in EDA are responsible for X-linked HED, the
most common form of HED (Kere et al., 1996), while dominant and
recessive mutations in EDAR and EDARADD have been found in
families carrying autosomal HED (Monreal et al., 1999; Headon et al.,
2001). The spontaneous mouse mutants EdaTa/Ta, EdardlJ/dlJ and
EdaraddCr/Cr (Srivastava et al., 1997; Monreal et al., 1999; Headon
et al., 2001) exhibit a similar phenotype to human HED in that the
development of the hair, teeth and exocrine glands is impaired
(Falconer et al., 1951; Grüneberg, 1965; Claxton, 1967; Grüneberg,
1971; Blecher et al., 1983). Analysis of Eda pathway mutant mice has
revealed that Eda signalling plays a role in SMG branching
morphogenesis (Jaskoll et al., 2003; Wells et al., 2010), but the role
of Eda signalling in minor SG development has not been examined
thoroughly. The classical study of gland development in EdaTa/Ta states
that lingual and palatal minor SGs are absent in EdaTa/Ta embryos
(Grüneberg, 1971), although it is unclear whether this represents
developmental delay or a failure of initiation. As well as the minor SG
defect, Grüneberg (1971) also reported that EdaTa/Ta embryos exhibit a
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back of the tongue associated with taste receptors and minor SGs.
Rescue of Eda pathway mutant phenotypes has been achieved
using a number of methods. Injection of a recombinant form of EDA
A1 given to pregnant EdaTa/Ta mothers leads to rescue of the organs
affected in the developing embryos (Gaide and Schneider, 2003),
although the effect on the SGs was not documented. In vitro, addition
of recombinant EDA A1 to EdaTa/Ta skin or SMG cultures rescues
primary hair placode andmajor SG branching respectively (Mustonen
et al., 2004; Wells et al., 2010). Recent qPCR proﬁling has revealed
downregulation of Shh and Fgf8 in EdaTa/Ta major SGs (Melnick et al.,
2009). The branching defect in Eda pathwaymutant SMG explants can
be rescued with Shh, but not Fgf8 (Wells et al., 2010). Shh is also a
target of Eda signalling in skin, but treatment of EdaTa/Ta skin with
exogenous Shh does not rescue primary hair placode formation
(Pummila et al., 2007).
In this paper we have sought to provide the ﬁrst characterization
of minor SG development in wild type (WT) and Eda pathwaymutant
mice, and to test the ability of exogenous EDA A1, Fgf8 and Shh to
rescue Eda pathwaymutant minor SGs using a novel minor SG culture
system.
Results
Eda pathway mutant embryos lack developing minor SGs
We began by analysing WT and Eda pathway mutant minor SG
histology during mouse embryogenesis. In theWT, the glands present
on the lateral part of the tongue are the ﬁrst to initiate. These glands
are ﬁrst visible at E15.5 as downgrowths of the posterior lateral
tongue epithelium. A number of lingual glands located closer to the
midline initiate slightly later, and are visible at E15.5 as small buds
(Fig. 1A, D). In EdaTa/Ta, EdardlJ/dlJ and EdaraddCr/Cr embryos of the same
stage, histological indications of developing minor SGs are absent
(Fig. 1B–C, E. EdaraddCr/Cr not shown).
In the E17.5 WT, some of the developing lingual glands have
formed distinct ductal and acinar structures, with hollowed out ducts
forming well deﬁned lumina. There is evidence of mucus production
at E17.5 and E18.5, as indicated by Alcian blue staining within the
ducts and end buds. In addition, a number of glands are now visible on
the palate (Fig. 1F,H,K). In Eda pathway mutant embryos of the same
stage, histological signs of developing minor SGs are absent (Fig. 1G,
I). The structures examined in the WT were conﬁrmed to be
developing minor SGs by in situ hybridisation of Nkx3.1 (Schneider
et al., 2000) (Fig. 1J).
The sequential appearance of minor SGs in different locations on
the tongue and palate was consistent in all the embryos we examined,
and we also noticed that glands simultaneously arose in identical
locations on the left and right sides of the embryo (Fig. 1A). This
indicates that the stage at which minor SGs develop, and their
positioning within the oral cavity, is highly regulated.
Mucous minor SGs are absent in Eda pathway mutant adults
To conﬁrm whether the embryonic Eda pathway mutant minor SG
defects persist into adulthood, we compared sections of adult Eda
pathway mutant and WT oral cavities (Fig. 2). In the WT, a large
number of mucous glands are present on the palate and tongue. A
number of serous glands are also observed in association with the CVP
(Von Ebner's glands) anterior to the lingual mucous glands (Fig. 2A).
In EdaTa/Ta, EdardlJ/dlJ and EdaraddCr/Cr, the tongue and palate were
characterized by an absence of mucous glands. The associated von
Ebner's glands (and other lingual serous glands) appeared normal
(Fig. 2B and C. EdaraddCr/Cr not shown). These data indicate that Eda
signalling is required for the initiation of the mucous subset of palatal
and lingual minor SGs.EdaTa/Ta mice exhibit a dysplastic CVP with disrupted Shh expression
While characterizing the minor SG phenotype in Eda pathway
mutants, we also examined the CVP. In agreement with the
observations of Grüneberg (1971), we conﬁrmed that the embryonic
CVP is dysplastic in EdaTa/Ta, EdardlJ/dlJ and EdaraddCr/Cr (Fig. 3A and B.
EdardlJ/dlJ and EdaraddCr/Cr not shown), appearing as a downward
ﬁssure rather than a raised dome. During WT early tongue
development, Shh is expressed in the developing epithelial dome of
the CVP where it is thought to regulate proliferation and epithelial
invagination leading to the structure's characteristic morphology (Lee
et al., 2006; Kim et al., 2009) (Fig. 3C). In EdaTa/Ta, Shh expression was
restricted to one side of the developing CVP and was absent from the
opposite wall of the dome where no epithelial trench had formed
(Fig. 3D). Therefore, in the absence of Eda, CVP Shh expression appears
disrupted, resulting in loss of the trench on one side.Eda, Shh and Fgf pathway genes are expressed from the earliest stages of
minor SG development
To shed light on the mechanisms regulating the induction and
early development of the minor SGs, we studied the expression of a
selection of genes during early minor SG development. Because minor
SGs fail to initiate in Eda pathway mutant mice, we ﬁrst chose to
examine Eda pathway activity. In addition, we examined the
expression of Shh and Fgf pathway genes, because these pathways
are possible targets of Eda signalling (Pummila et al., 2007; Melnick
et al., 2009). To study Eda pathway activity, we examined the
expression of Edaradd, since the expression of this gene likely reﬂects
the location where the pathway is acting. At E15.5, Edaradd was
expressed in the budding minor SGs and throughout the oral
epithelium (Fig. 3E and F). At the same stage, Shh mRNA was weakly
detected in the budding glands but not throughout the oral
epithelium (except in the developing rugae) (Fig. 3G and H). Ptc1,
the Shh signalling receptor and target, was expressed in the budding
glands, particularly at the distal portion of the bud (Fig. 3I). To
examine Fgf signalling activity, we studied the expression of Erm, an
Ets-family transcription factor target of Fgf signalling (Wasylyk et al.,
1998). Erm was detected strongly in the budding glands at an early
stage of development. Erm expression was conﬁned to the developing
glands, and was not detected in the oral epithelium (Fig. 3J).Minor SGs fail to develop in EdaTa/Ta tongue explants
We developed a novel minor SG culture system allowing us to
follow the development of lingual minor SGs in tongue explants. After
development of E13.5 WT whole tongues for 48 hours in vitro,
developing minor SG buds were visible at the posterior lateral area of
the tongue (Fig. 4A). Minor SG buds were absent in EdaTa/Ta tongues at
this stage (Fig. 4C). After 72 hours in culture, more buds were visible
on the lateral WT tongue, and further buds appeared closer to the
midline (Fig. 4B), in agreement with our histological data. Developing
lingual glands remained absent in EdaTa/Ta tongues at this stage
(Fig. 4D).
To quantify these observations, the tongue explants were
sectioned and subjected to histology staining and in situ hybridisation
of an Nkx3.1 probe. Developing minor SGs, as deﬁned by Nkx3.1
expressing epithelial thickenings, were counted over all sections from
each explant, and the number of developing glands inWT, EdaTa/+ and
EdaTa/Ta explants compared. While no Nkx3.1 expressing regions were
present in EdaTa/Ta tongues (Fig. 4F, H, I), a mean of ~6 Nkx3.1 positive
developing lingual glands were present in WT tongues (Fig. 4E, G, I).
Nkx3.1 positive lingual glands were present in EdaTa/+, but appeared
reduced in number in comparison with WTs (Fig. 4I).
Fig. 1. Minor SGs are absent in Eda pathway mutant embryos. Frontal sections. (A) E15.5 WT oral cavity showing epithelial buds and downgrowths (arrows). (B) E15.5 EdaTa/Ta
(n=6) oral cavity stage matched to (A). Developing minor SGs are absent. (C) E15.5 EdardlJ/dlJ (n=5) oral cavity stage matched to (A) showing similar absence of developing minor
SGs. (D) High magniﬁcation of E15.5 WT oral cavity showing downgrowth of the posterior lateral tongue epithelium (arrow), and additional buds towards the midline. (E) High
magniﬁcation of EdaTa/Ta tongue epithelium. Developing minor SGs are absent. (F) E17.5 WT oral cavity. A number of developing lingual and palatal minor SGs are seen (arrows). (G)
E17.5 EdaTa/Ta (n=3) oral cavity stage matched to (F). Developing minor SGs remain absent. (H) High magniﬁcation of E17.5 WT lingual gland. Distinct ductal and acinar structures
have formed, and the duct exhibits a well-deﬁned lumen. Alcian blue staining indicates mucus production. (I) High magniﬁcation of E17.5 EdaTa/Ta oral cavity showing absence of
developingminor SGs. (J) E17.5 oral cavity. Nkx3.1 is expressed in developing minor SGs (arrows). (K)WT E18.5 oral cavity. Alcian blue staining indicates differentiated glands on the
tongue and a number of palatine minor SGs are present (arrows). nc, nasal cavity; oc, oral cavity; t, tongue; p, palate. Scale bar in A (for A–C, J)=200 μm. Scale bar in D (for D, E)
=100 μm. Scale bar in F (for F, G, K)=500 μm. Scale bar in H (for H, I)=100 μm.
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Fig. 2. Mucous minor SGs are absent in Eda pathway mutant adults. Trichrome stained sagittal sections of the oral cavity in 6-week-old mice. (A) WT FVB/N tongue and palate
showing Alcian blue stained mucous minor SGs (arrows) and unstained lingual serous minor SGs (double arrows). CVP indicated by arrowhead. (B) EdaTa/Ta (n=3) tongue and
palate. Mucous minor SGs are absent, but lingual serous SGs are present (arrows). (C) EdardlJ/dlJ (n=3) tongue and palate. Mucous minor SGs are absent as in (B). t, tongue; oc, oral
cavity; p, palate. Scale bar in A (for A–C)=500 μm.
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We investigated whether minor SG induction can be rescued by
recombinant EDA A1 supplementation in vitro. E13.5 EdaTa/Ta and
EdaTa/+ tongues were cultured with 500 ng/mL EDA A1, and control
tongues were cultured in the absence of EDA A1. After 4 days in
culture, tongue explants were sectioned and subjected to histology
staining and in situ hybridisation of an Nkx3.1 probe. Developing
minor SGs, as deﬁned by Nkx3.1 expressing epithelial thickenings,
were counted over all sections from each explant, and the mean
number of developing glands in treated and control explants
compared. While no Nkx3.1 expressing regions were present in
control EdaTa/Ta tongues (Fig. 5A, C, E), a mean of ~4 Nkx3.1 positive
developing lingual glands were present in EDA A1 treated EdaTa/Ta
tongues (Fig. 5B, D, E). A trend towards increasedminor gland number
was also observed in WT and EdaTa/+ tongues treated with EDA A1 in
comparison with untreated WT tongues (Fig. 5E).
Exogenous Shh and Fgf8 do not fully rescue minor gland induction in
EdardlJ/dlJ
We tested whether application of exogenous Shh or Fgf8, potential
targets of Eda signalling, would result in rescue of the minor SGs in
Eda pathway mutant tongues. For these experiments, we moved to
EdardlJ/dlJ tongues. These mice lack functional Edar, and we considered
them the best system for a downstream rescue since the possibility of
activating signalling via Edar is abolished. E13.5 EdardlJ/dlJ tongues
were cultured with either 500 ng/mL Fgf8b or 2.5 μg/mL Shh-N
peptide, and control tongues were cultured in the absence of
recombinant protein. These proteins were also tested simultaneously
on SMG explants to conﬁrm that they were functional (Wells et al.,
2010). After 4 days in culture, tongue explants were sectioned and
subjected to histology staining and in situ hybridisation of an Nkx3.1
probe. No Nkx3.1 expression was detected in control EdardlJ/dlJ
explants. In 3/19 Fgf8b-treated tongues, weak Nkx3.1 expression
was evident in 1 or 2 gland-like structures, indicating possible rescue
of minor SGs in a limited number of explants (Fig. 6A–D). No Nkx3.1
expression was detected in Shh-treated EdardlJ/dlJ explants, although
Nkx3.1-negative gland like structures were noted. In location and
morphology, these structures were similar to minor SGs, suggestingFig. 3. Dysplastic CVP in EdaTa/Ta andminor SG gene expression. Frontal sections. (A) E15.5WT ora
cavity stagematched to (A)TheCVP isdysplastic (arrowhead)and the trencheseither sideof thedo
CVPdome (arrowhead). Expression is absent from the trenches (outlined). (D) Serial section to (B)
E15.5 oral cavity showingdevelopingminor SG(arrow). (F)E15.5 35S in situhybridisation.Edaradd
cavity showing Shh expression in developingminor SG (arrow) and palatal rugae. (H) High power
(arrow), especially at thedistal portionof thebud. (J) E16.5 in situhybridisation. Erm is expressed in
J)=100 μm. Scale bar in E (for E–G)=200 μm. Scale bar in H (for H–I)=50 μm.that Shh causes the induction of a small number of glands which then
do not develop further (Fig. 6E–H, J). Expression of Nkx3.1 was
detected in developing glands in EdardlJ/+ tongues as expected
(Fig. 6I).
Discussion
Minor SGs develop by epithelial downgrowth and are highly regulated
Our data represents, to our knowledge, the ﬁrst thorough
description of minor SG development in the mouse. We show that
the minor SGs develop by epithelial thickening and budding, and
subsequent downgrowth and differentiation. However, unlike the
SMGs, the minor SGs lack a mesenchyme capsule (Hand et al., 1999).
This raises the question of where the signals instructing the
positioning and development of the glands reside. Recombination
experiments have shown that major SG branching is driven by the
surrounding mesenchyme (Grobstein, 1953), but it has been
speculated that the initiation signals may come from the oral
epithelium as in the developing tooth (Tucker, 2007). Our data
showing that the minor glands are able to initiate development
without signals from a mesenchyme capsule certainly suggests that
the major SGs may be able to do the same, only requiring
mesenchymal signals to instruct later branching morphogenesis. It
is tempting to speculate that the minor SGs do not branch extensively
because they do not have access to such stimulatory signals as those
secreted by the major SG mesenchyme.
To date the only known marker of developing minor SGs was
Nkx3.1 (Schneider et al., 2000). Here we show that Edaradd, Shh, Ptc1
and Erm also mark the minor SGs from the earliest stages of their
development. Shh is a knownmitogen (Ingham and McMahon, 2001)
and it seems likely that its function in the developing minor SG is to
promote proliferation and epithelial downgrowth, as in the develop-
ing hair follicle (Millar, 2002). In addition, our data showing
expression of both Ptc1 and Shh in the epithelium, rather than in
separate tissue compartments, indicates that Shh signalling regulates
minor SG development in an autocrine manner. Fgf signalling is
required for major SG development (reviewed in Tucker (2007)), and
our ﬁnding of strong Erm expression in the developing minor SGs is in
agreement with this.l cavity, showing developing CVP (arrowhead)with trenches outlined. (B) E15.5 EdaTa/Ta oral
meareuneven indepth (outlined). (C) Serial section to (A). Shh is expressed in thedeveloping
showing restriction of Shh expression to one side of developing EdaTa/Ta CVP. (E)H&E stained
is expressed in theoral epitheliumandminor SG(arrow). (G) In situhybridisationofE15.5 oral
of dashed box in (G). (I) E16.5 In situ hybridisation. Ptc1 is expressed in developingminor SG
thedevelopingminor SGs (arrows). oc, oral cavity; t, tongue; p, palate. Scale bar inA (forA–D,
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Our data showing Eda pathway gene expression in the developing
minor SGs and our analyses of minor SG development in Eda pathwaymutant mice indicate a requirement for Eda signalling in minor SG
initiation. The observation that EdaTa/+ embryos exhibit a mild
phenotype with respect to their minor SGs indicates that levels of Eda
signalling are important in minor SG development. This idea ﬁts with
Fig. 4.Minor SGs fail to develop in EdaTa/Ta tongue explants. Tongue explants in culture (A–D) and sectioned (E–H). Insets in A–D show highmagniﬁcation of dashed boxes. (A) E13.5
WT tongue explants after 48 hrs in culture. Lingual epithelial buds are visible (outlined). (B) Explant shown in (A) after 72 h in culture. More epithelial buds are visible on lateral
tongue and towards the midline (outlined). (C) E13.5 EdaTa/Ta tongue explant after 48 h in culture. Budding minor SGs are absent. (D) Explant shown in (C) after 72 hrs in culture.
Developing minor SGs remain absent. (E) E13.5+72 hWT posterior tongue section (trichrome stained). Developing lingual glands are apparent (arrows). (F) E13.5+72 hrs EdaTa/Ta
posterior tongue section. Developing lingual glands are absent. (G) Serial section to (E), showing Nkx3.1 expression in developing lingual glands (arrows). (H) Serial section to (F).
Nkx3.1 expression is absent. (I) Chart representing mean lingual gland number counted per genotype group. Number of explants per group: EdaTa (n=7), EdaTa/+ (n=3), WT
(n=6). Error bars represent one standard error±mean. Scale bar in A (for A–D)=1000 μm. Scale bar in E (for E–H)=200 μm. * indicates hyoid cartilage.
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saliva ﬂow (Lexner et al., 2007). No information is yet available on the
signalling mechanisms involved in initiating development of major or
minor SGs; our work indicates an involvement for Eda signalling. The
literature also lacks information on genes involved in determining the
type of SG that will develop. The speciﬁc requirement for Eda inmucousminor SG initiation contrasts with the case of the SMGs (Melnick et al.,
2009) and serous minor SGs, which do not require Eda signalling for
initiation, and evokes the different requirements for Eda in the distinct
types of hair follicles. In EdaTa/Ta, secondary and tertiary hair follicles
initiate normally, but primary hair follicles fail to initiate (Laurikkala et
al., 2002).
Fig. 5. Exogenous EDA A1 rescues lingual gland development in EdaTa/Ta. Trichrome stained sections of E13.5 tongue explants cultured for 4 days (A–B), and serial sections subjected
to Nkx3.1 in situ hybridisation (C–D). (A) EdaTa/Ta posterior tongue showing lack of developing lingual glands and (B) Nkx3.1 expression. (C) EdaTa/Ta posterior tongue treated
with 500 ng/mL EDA A1 in vitro. Rescued lingual glands are apparent (arrows). (D) Serial section to (C).Nkx3.1 is expressed in rescued lingual glands (arrows). (E) Chart representing
mean lingual gland number counted per genotype and treatment group. Number of explants per group: EdaTa/Ta (n=7), EdaTa/Ta+EDA (n=8), EdaTa/+ (n=3), EdaTa/+ + EDA
(n=3), WT (n=6), WT+EDA=(n=5). Error bars represent one standard error±mean. Scale bar in A (for A–D)=200 μm.
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A1 in vitro
Using ourminor SG culture system, we show that supplementation of
E13.5 EdaTa/Ta tongues with EDA A1 results in rescue of gland
development. This agrees with data showing that exogenous EDA A1
rescues primary hair follicle development in EdaTa/Ta skin explants
(Laurikkala et al., 2002). EDA A1 injection has been shown to rescue
most aspectsof theEdaTa/Taphenotype(GaideandSchneider, 2003)andas
a result recombinant EDAA1 is promising a cure for sufferers of HED. HED
patients demonstrate reducedwhole salivaﬂow(Nordgardenet al., 2001)
leading to xerostomia (dry mouth), a reduced quality of life and further
damage to an already compromised dentition. However, the ability of this
protein to rescueminor SG development in EdaTa/Ta had not been studied.
Our ﬁndings are encouraging for future attempts to correct SG defects in
HED patients. Although our histological studies showed an absence of
minor SGs in Eda pathwaymutant embryos, the fact that these glands are
rescued with EDA A1, and that they develop in the expected position,
implies that a groupof cells able to respond to the signal are in fact present
in Eda pathway mutants.Exogenous Shh and Fgf8 donot fully rescueminor gland induction in EdardlJ/dlJ
QPCR data has indicated that Shh is a potential target of Eda
signalling in the SMGs (Melnick et al., 2009), and treatment of
embryonic EdaTa/Ta skin cultures with recombinant EDA A1 results in
upregulation of Shh (Pummila et al., 2007). A number of Nkx3.1
expression domains in the developing embryo, such as the prostate
gland, are dependent on Shh (Schneider et al., 2000). We were unable
to demonstrate rescue of Nkx3.1 expression in EdardlJ/dlJ tongue
explants by Shh supplementation, although we did observe the
presence of gland-like tissue. Shh overexpression is associated with
tumour formation in the skin (Oro et al., 1997), and it is possible that
the tissue we observe is the result of overproliferation. Our ﬁnding
that Shh is not sufﬁcient to completely rescue minor SG development
in the absence of Eda signalling agrees with data showing that
exogenous Shh is unable to rescue primary hair placode induction in
EdaTa/Ta skin cultures (Pummila et al., 2007).
Fgf8 is another potential target of Eda signalling in the SMGs
(Melnick et al., 2009). Other studies have shown growth factor
mediated rescue of aspects of the EdaTa/Ta phenotype. EGF injection
Fig. 6. Exogenous Fgf8 and Shh donot fully rescue lingual gland development in EdardlJ/dlJ. E13.5 tongue explants after 4 days in culture. (A) Trichrome stained section of EdardlJ/dlJ posterior
tongue showing lack of developing lingual glands and (C) serial section showing lack ofNkx3.1 expression. (B) Trichrome stained section of EdardlJ/dlJ tongue treatedwith 500 ng/mL Fgf8b.
Gland-like structures are evident (arrows). (D) Serial section to (B). Nkx3.1 is weakly expressed in these structures (arrows). (E) EdardlJ/dlJ control tongue explant. (F) EdardlJ/dlJ tongue
explant treatedwith 2.5 μg/mL Shh-N.Rescuedgland-like structures are evident (arrow). (G) Trichromestained section of control EdardlJ/dlJ tongue. (H) Trichrome stained section ofEdardlJ/
dlJ tongue treatedwith 2.5 μg/mL Shh-N showing gland-like structures (arrows). (I) Control EdardlJ/+ tongue section.Nkx3.1 expression is detected in developing lingual gland (arrow). (J)
Serial section to (H). Nkx3.1 is not expressed in the gland-like structures. Scale bar in A (for A–D, G–J)=100 μm. Scale bar in E (for E–F)=200 μm.
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(Blecher et al., 1990). In embryonic EdaTa/Ta tooth explants, cusp
morphogenesis is partially rescued by exogenous Fgf10 (Pispa et al.,
1999), although it is unclear whether this is through a mechanismindependent of Eda signalling, such as an increase in epithelial
proliferation. In our study, 3 out of 19 cultures showed induction of
Nkx3.1-positive minor SG structures in response to Fgf8 supplemen-
tation, indicating that Fgf8 is not sufﬁcient to rescue reliably. This may
145K.L. Wells et al. / Developmental Biology 349 (2011) 137–146be due to the greater importance of alternative Fgf ligands inminor SG
development, or a subtle difference in the developmental stage of the
tongue explants which did show a rescue. It seems plausible that
neither Fgf8 nor Shh are able to act alone in minor SG development
and may require other factors for normal morphogenesis, or act in
concert with each other.
Materials and methods
Animals
All Eda pathway mutant mice were on the FVB/N background. E13.5
WT, EdaTa/+ and EdaTa/Ta embryos were obtained from EdaTa/+ females
crossed with EdaTa/Y males. E13.5 EdardlJ/dlJ and EdardlJ/+ embryos were
obtained from EdardlJ/+ females crossed with EdardlJ/dlJ males. E15.5 and
E17.5 EdaTa/Ta, EdardlJ/dlJ and EdaraddCr/Cr embryos were obtained from
homozygous females crossed with hemi-/homozygous males. In the text,
EdaTa/Ta refers to EdaTa/Ta females and EdaTa/Y males: EdardlJ/dlJ and
EdaraddCr/Cr refer to homozygous animals. CD1 mice were bred to obtain
stage matched control animals where required. Pregnant females were
sacriﬁced by cervical dislocation and noon on the day of discovery of the
vaginal plug was designated day 0.5 of development. Embryos were
harvested and decapitated in phosphate buffered saline (PBS) for
immediate ﬁxation, or in complete culture medium (Advanced Dulbecco
modiﬁed Eagle's minimal essential medium F-12 (DMEM-F12) (Gibco,
Invitrogen) supplemented with 1% penicillin/streptomycin and 1%
Glutamax (Gibco, Invitrogen)) for tongue culture experiments.
Genotyping
DNA was extracted by digestion of tail snip tissue in 0.5 mg/mL
proteinase K at 55 °C overnight, followed by phenol chloroform puriﬁ-
cation and ethanol precipitation. Genotype of E13.5 WT, EdaTa/+ and
EdaTa/Ta embryos was identiﬁed by PCR analysis using primer sets spe-
ciﬁc for Eda (covering the exon1 region deleted in EdaTa/Ta and therefore
failing to generate a product fromEdamutantDNA), Y chromosomeand
Actin (for positive control). Primer sequences were: EDA: 5′-AGGA-
CAGTAGTCGCCTGT-3′ (forward), 5′-GCCGCCGCCCTTCCTAGG-3′ (re-
verse). Y chromosome: 5′-CTGGAGCTCTACAGTGATGA-3′ (forward),
5′-CAGTTACCAATCAACACATCAC-3′ (reverse). Actin: 5′-GCTTCTGA-
GATGTCTCTCTCT-3′ (forward), 5′-ACACAGGCTTTTGTAGGTTGC-3′ (re-
verse). These primers generated 509 bp (Eda), 343 bp (Y chromosome)
and 159 bp (Actin) fragments.
The Edar mutant animals used in this study were of the
downlessJackson strain which possess a G to A point mutation within
the Edar death domain (Headon and Overbeek, 1999). Genotype of
E13.5 EdardlJ/dlJ and EdardlJ/+ embryos was determined by PCR analysis
using Edar speciﬁc primers, the forward primer containing a one
nucleotide mismatch from the template DNA. The mismatch enabled
the generation of a TaqI restriction site unique to the WT sequence.
Primer sequences were 5′-TGAAAACATGGCGCCACCTTGTC-3′ (for-
ward, mismatch underlined), 5′-TCACTCACAGCTGTCGGTCGTG-3′
(reverse). These primers generated a 309 bp product. Overnight
digestion of EdardlJ/dlJ product with TaqI (Sigma) at 65 °C resulted in
142 bp and 167 bp fragments (due to a natural TaqI site within the
PCR product), whereas restriction of EdardlJ/+ product resulted in
fragments of 167 bp, 142 bp, 120 bp and 22 bp. Fragments were
visualised on a 3% agarose gel. The mismatch primer was designed
using dCAPS Finder 2.0 online software.
PCR cycling conditions were as follows: 94 °C 2 min 30 s, 94 °C
30 s, 54 °C 30 s, 72 °C 1 min for 36 cycles.
Tissue processing and sectioning
Tissueswereﬁxed in4%paraformaldehyde(PFA)at4 °Covernight and
washed in PBS before dehydration in a methanol and isopropanol series,and clearing in 1,2,3,4-tetrahydronaphthalene. Adult heads were addi-
tionally subjected to decalciﬁcation in 1% PFA and 25% 0.5 M EDTA in PBS
for 2 weeks prior to dehydration. Cleared samples were incubated in
parafﬁnwax at 65 °C before embedding inmoulds. Sections were cut to a
thickness of 8 μm, mounted on glass slides (Superfrost Plus™, VWR
International) and dried on a 42 °C hotblock overnight.
In situ hybridisation
Radioactive in situ hybridisation of 35S-UTP-labelled Edaradd probe
was performed as described in Tucker et al. (1999). Edaradd was
linearized with Spe1 and transcribed with T3. Sections were counter-
stained with methyl green and photographed under darkﬁeld. In situ
hybridisation of dioxygenin-labelled Shh, Ptc1, Erm and Nkx3.1 probes
was performed according to modiﬁed Wilkinson procedures (Wilk-
inson, 1995) and sections were counterstained with eosin. Shh was
linearized with EcoRI and transcribed with T7. Nkx3.1 was linearized
with EcoRV and transcribed with T7. Ptc1 was linearized with BamHI
and transcribed with T3. Erm was linearized with HindIII and
transcribed with T7.
Histology staining
Sections were cleared with Histoclear™, rehydrated through an
ethanol series and washed in dH2O. Sections were stained with
haemotoxylin and eosin (H&E) and differentiated in acid alcohol, or
alternatively were stained with Sirius red in picric acid, Alcian blue
and haemotoxylin (trichrome) where appropriate. After staining,
sections were washed in dH2O, dehydrated through an ethanol
series, cleared in xylene and coverslipped with DPX mounting
medium.
Organ culture
Tongues were dissected whole in complete culture medium and
care was taken to remove all SMG tissue. Explants were mounted on
membranes (BD Falcon cell culture inserts) and ﬂoated over culture
medium in glass bottom dishes (MatTek Corporation). Medium for
experimental explants was supplemented with recombinant Fc-EDA
A1 (Gaide and Schneider, 2003) Fgf8b, or Shh-N peptide (R&D
Systems). Explants were cultured in a 37 °C, 5% CO2 incubator,
photographed and the medium changed daily.
Analysis
Unpaired t-tests were performed for statistical comparison of
groups of data and p values are shown in the ﬁgures. Data were
analysed and converted to charts using Microsoft Ofﬁce Excel 2007.
The level of statistical signiﬁcance was taken as pb0.05.
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